Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

2.1K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
Peritoneum01:21

Peritoneum

12.9K
The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
12.9K
Ascites01:19

Ascites

52
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The European Society of Pediatric Nephrology Board Examination-a certified benchmark of knowledge and clinical practice with global recognition.

Pediatric nephrology (Berlin, Germany)·2026
Same author

A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination.

Expert review of anticancer therapy·2026
Same author

Drug prescription for patients treated by dialysis: navigation in the fog.

Clinical kidney journal·2026
Same author

Mineral, Bone, and Cardiovascular Disorders in CKD: The Case for a New Paradigm.

Kidney medicine·2026
Same author

Protecting Kidneys by Protecting the Planet: A Pediatric Nephrology Perspective for World Kidney Day 2026.

Turkish archives of pediatrics·2026
Same author

Prevention is better than cure: role of RAAS blockade in preventing catastrophic hypotension after bilateral native nephrectomies in infants.

Pediatric nephrology (Berlin, Germany)·2026

Related Experiment Video

Updated: May 5, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K

Encapsulating peritoneal sclerosis in children.

Constantinos J Stefanidis1, Rukshana Shroff

  • 1Department of Nephrology, "P. & A. Kyriakou" Children's Hospital of Athens, Thivon and Levadias Str, Goudi, 14562, Athens, Greece, cjstefanidis@gmail.com.

Pediatric Nephrology (Berlin, Germany)
|November 22, 2013
PubMed
Summary

Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis (PD). Pediatric EPS has a better outcome and lower mortality compared to adults, though risk increases with longer dialysis duration.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

707
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Related Experiment Videos

Last Updated: May 5, 2026

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

1.9K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

707
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Area of Science:

  • Nephrology
  • Pediatric Nephrology

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a severe complication of peritoneal dialysis (PD).
  • While recognized in adults, pediatric EPS cases are less frequently described.
  • Children may undergo long-term PD before kidney transplantation.

Purpose of the Study:

  • To review current knowledge on the epidemiology, pathogenesis, and management of pediatric EPS.
  • To raise awareness among pediatric nephrologists about this serious complication.
  • To highlight the need for collaborative research and a dedicated pediatric EPS registry.

Main Methods:

  • Review of data from two European pediatric PD registries.
  • Analysis of prevalence, risk factors, and outcomes of pediatric EPS.
  • Synthesis of existing literature on EPS in children on PD.

Main Results:

  • Pediatric EPS prevalence is comparable to adult registries.
  • Outcomes for pediatric EPS are significantly better with lower mortality than in adults.
  • A longer duration of PD (dialysis vintage) is associated with increased EPS risk.

Conclusions:

  • Pediatric EPS, though rare, requires vigilance from healthcare providers.
  • Understanding susceptibility factors for EPS development remains crucial.
  • Future collaborative research and a registry are vital for early detection, prevention, and optimal management strategies.